Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Schoenecker, Rebecca
NCT05822583: Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial	Recruiting	4	1500	Europe, US, RoW	abatacept infusion, Placebo group	University of Minnesota	COVID-19	07/25	07/25
NCT05605093: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)	Recruiting	3	1500	Europe, Japan, US, RoW	Shionogi Protease Inhibitor (S-217622), ensitrelvir, placebo	University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID)	COVID-19	07/25	07/25
ICC, NY
NCT05822583: Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial	Recruiting	4	1500	Europe, US, RoW	abatacept infusion, Placebo group	University of Minnesota	COVID-19	07/25	07/25